Newsroom

Verantos launches platform for high-validity RWE

Press Releases

Verantos, the global leader in high-validity real-world evidence (RWE), recently announced the launch of the Verantos Evidence Platform. The Verantos Evidence Platform provides life sciences organizations with the ability to generate RWE that meets the highest evidentiary standards, including those defined by Food and Drug Administration (FDA) draft guidance.

Read at the original outlet
All news
Get started

Ready to advance your evidence program?

Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.